Venostent, Inc.
Houston, TX 1985
- UEI
- WLHLGMAJEAQ3
- CAGE
- 7ZYJ9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2450 Holcombe Blvd b, Houston, TX 77021, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Pilot-scale synthesis for the commercialization of a novel, bioabsorbable perivascular wrap to improve outcomes in… | National Heart Lung and Blood Institute | $1,016,974 | |
| Save-fistulas: a pivotal study of selfwrap-assisted arteriovenous fistulas - project summary/abstract arteriovenous… | National Heart Lung and Blood Institute | $7,324,352 | |
| Biodegradability and biocompatibility of a shape memory polymer wrap to improve saphenous vein graft patency in… | National Heart Lung and Blood Institute | $299,910 | |
| Sbir phase II: hemodynamic optimization and preclinical assessment of a shape memory polymer wrap to reduce hemodialysis… | Division of Industrial Innovation | $1,294,224 | |
| Sttr phase i: hemodynamic effects inform design of an external stent to reduce dialysis access failures | Division of Industrial Innovation | $224,482 |
About Venostent, Inc.
Venostent, Inc. 1985 Division is a for-profit corporate entity registered to receive federal government awards since November 2017. The company specializes in developing innovative medical devices to address critical challenges in vascular surgery, particularly focusing on improving outcomes for patients undergoing arteriovenous fistula (AVF) creation and other vascular procedures. Venostent's primary focus appears to be the development of a bioabsorbable perivascular wrap called SelfWrap, designed to support veins as they adapt to arterial circulation following surgical connections. This technology aims to reduce complications and improve success rates in procedures such as hemodialysis access creation, peripheral artery bypass grafting, and coronary artery bypass grafting.
The company has received multiple federal grant awards to support its research and development efforts. A significant project funded by the National Heart Lung and Blood Institute (NHLBI) involves a pivotal study of the SelfWrap device for arteriovenous fistulas. This study, awarded in April 2020, aims to evaluate the safety and effectiveness of SelfWrap in chronic kidney disease patients undergoing AVF creation. Another NHLBI-funded project focuses on assessing the biodegradability and biocompatibility of the shape memory polymer wrap for improving saphenous vein graft patency in peripheral and coronary artery bypass grafting surgeries. Additionally, Venostent received funding from the National Science Foundation for an SBIR Phase II project to optimize the hemodynamics and conduct preclinical assessments of the shape memory polymer wrap for reducing hemodialysis access site failures. These grants demonstrate Venostent's commitment to advancing vascular surgery techniques and improving patient outcomes through innovative medical device development.
Quick answers
What is Venostent, Inc.'s UEI?
Venostent, Inc.'s Unique Entity ID (UEI) in SAM.gov is WLHLGMAJEAQ3.
What is Venostent, Inc.'s CAGE code?
Venostent, Inc.'s CAGE code is 7ZYJ9.
Where is Venostent, Inc. located?
Venostent, Inc.'s physical address in SAM.gov is 2450 Holcombe Blvd b, Houston, TX 77021, USA.
Is Venostent, Inc. registered in SAM.gov?
Yes. Venostent, Inc.'s SAM.gov registration is active through January 19, 2027.
What is Venostent, Inc.'s most recent federal award?
Venostent, Inc.'s most recent federal grant award is Pilot-scale synthesis for the commercialization of a novel, bioabsorbable perivascular wrap to improve outcomes in… (R44HL187038), from National Heart Lung and Blood Institute, on September 1, 2026.
On GovTribe
See Venostent, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors